Immunome Inc. (IMNM) earnings
Quarterly results of Immunome Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Immunome Inc. is expected to report around March 2, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Latest quarter: Q3 FY2026
In Q3 FY2026 (ended September 30, 2026) Immunome Inc. reported revenue of $0 and a net loss of $85.8M.
Diluted earnings per share were -$0.76.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q3 FY2026 | $0 | - | -$85.8M | -$0.76 |
| Q2 FY2026 | $0 | - | -$73.1M | -$0.65 |
| Q1 FY2026 | $0 | - | -$53.8M | -$0.48 |
| Q4 FY2025 | $0 | - | -$69.9M | - |
| Q3 FY2025 | $0 | - | -$57.5M | -$0.65 |
| Q2 FY2025 | $4M | - | -$43.4M | -$0.50 |
| Q1 FY2025 | $2.9M | - | -$41.6M | -$0.52 |
| Q4 FY2024 | $2.7M | - | -$80.2M | - |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
When is Immunome Inc.'s next earnings date?
Immunome Inc. is expected to report around March 2, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
What were Immunome Inc.'s latest quarterly results?
For Q3 FY2026, which ended September 30, 2026, Immunome Inc. reported revenue of $0 and a net loss of $85.8M. The figures come from its filing with the SEC.
Get an email when IMNM reports
Follow IMNM and we email you its next results the day they are filed, with the numbers explained.